733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy

Evisa Gjini; Jimena Trillo-Tinoco; Andrew Browne; Ryan Powles; Tai Wang; Christine Tauras; Ana Lako; Ruben Ferrer-Luna; Zoe Bleicher; Timothy Consedine; Chensheng Zhou; Evan Kelemen; Anne Lewin; Catherine King; Sumit Bhattacharya; Harris Bell-Temin; Ashok Dongre; David Nelson; Christos Hatzis; Kenzie Macisaac; Fadi Towfic; Benjamin Chen; Michaela Bowden

doi:10.1136/jitc-2020-SITC2020.0733

Article info

Regular and young investigator award abstracts

Tumor and stromal cell biology

733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy

Authors

Evisa Gjini Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Jimena Trillo-Tinoco Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Andrew Browne Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Ryan Powles Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Tai Wang Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Christine Tauras Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Ana Lako Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Ruben Ferrer-Luna Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Zoe Bleicher Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Timothy Consedine Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Chensheng Zhou Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Evan Kelemen Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Anne Lewin Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Catherine King Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Sumit Bhattacharya Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Harris Bell-Temin Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Ashok Dongre Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
David Nelson Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Christos Hatzis Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Kenzie Macisaac Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Fadi Towfic Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Benjamin Chen Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles
Michaela Bowden Bristol-Myers Squibb, Cambridge, MA, USA PubMed articles Google scholar articles

Citation

Gjini E, Trillo-Tinoco J, Browne A, et al

733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy

Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0733

Online issue publication

December 12, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password